New clinical trials are advancing in hard-to-treat cancers, offering targeted and less toxic options for patients with ...

Farber, with the creation of a new cancer hospital, is moving forward after the completion of the regulatory process.

An estimated 20 million people are diagnosed annually with cancer, while cancer kills almost 10 million people a year worldwide ( ) with these numbers expected to grow. The American Cancer Society ...

Mississippi had the highest mortality rate across all cancer types between 2018 and 2022, according to data published by the American Cancer Society.  The American Cancer Society used data from the ...

AstraZeneca (LSE:AZN) received EU approval for its cancer treatment Imfinzi, marking a significant product-related milestone.

A fundraiser has been set up to help a Sanibel resident and member of the island and business community with her husband’s ...

Every bladder cancer journey is different, and no single treatment or diagnostic path fits everyone. According to patients who have experienced bladder cancer, the best care for you will depend on ...

CG Oncology, Inc. (NASDAQ:CGON) is one of the 13 Best Pharma Stocks to Buy According to Wall Street Analysts. On June 17, ...

UroGen Pharma Ltd. (NASDAQ: URGN) is one of the best hot stocks to buy according to Wall Street analysts. In mid-June, UroGen ...

Second-look TURBT showed limited value in altering outcomes for high-grade Ta bladder cancer after complete resection.

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

(Alliance News) - AstraZeneca PLC on Friday said Imfinzi is "poised to transform the standard of care" as it reported the bladder cancer treatment cleared a European regulatory milestone.